NIDDK international conference report on diabetes and depression: Current understanding and future directions

Diabetes Care

Volumn 37, Issue 8, 2014, Pages 2067-2077

  Holt, Richard I G ^a   De Groot, Mary ^b   Lucki, Irwin ^c   Hunter, Christine M ^d   Sartorius, Norman ^e   Golden, Sherita H ^f  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e Association for the Improvement of Mental Health Programmes   (Switzerland)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; INSULIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; GLUCOSE BLOOD LEVEL;

AUTONOMIC DYSFUNCTION; COMORBIDITY; CONFERENCE PAPER; CONTINUING EDUCATION; CULTURAL FACTOR; DEPRESSION; DETERIORATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE RESISTANCE; EATING HABIT; ENVIRONMENTAL FACTOR; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC DISORDER; NATIONAL HEALTH ORGANIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PATIENT CARE; PSYCHOTHERAPY; SEDENTARY LIFESTYLE; SLEEP DISORDER; TREATMENT RESPONSE; DEPRESSIVE DISORDER; DIABETIC NEPHROPATHY; FORECASTING; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; ORGANIZATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; UNITED STATES;

BLOOD GLUCOSE; CONGRESSES AS TOPIC; DEPRESSIVE DISORDER; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FORECASTING; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; PITUITARY-ADRENAL SYSTEM; RISK FACTORS; SEDENTARY LIFESTYLE; SLEEP WAKE DISORDERS; UNITED STATES;

EID: 84905027363     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2134     Document Type: Conference Paper

References (72)

1. Holt RI, Katon WJ Dialogue on Diabetes and Depression: Dealing with the double burden of co-morbidity. J Affect Disord 2012; 142(Suppl.): S1-S3
2. Sartorius N, Cimino L. The Dialogue on Diabetes and Depression (DDD): Origins and achievements. J Affect Disord 2012; 142(Suppl.): S4-S7
3. NIH/NIDDK International Conference on Diabetes and Depression. Available from http://www2.niddk.nih.gov/News/Calendar/Diabetes-Depression12.htm. Accessed 19 September 2012
4. Fisher EB, Chan JC, Nan H, Sartorius N., Oldenburg B. Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge. J Affect Disord 2012; 142(Suppl.): S56-S66
5. Anderson RJ, Freedland KE, Clouse R.E., Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069-1078
6. Pouwer F, Nefs G, Nouwen A. Adverse effects of depression on glycemic control and health outcomes in people with diabetes: a review. Endocrinol Metab Clin North Am 2013; 42: 529-544
7. Reynolds KA, Helgeson VS Children with diabetes compared to peers: depressed? Distressed? A meta-analytic review. Ann Behav Med 2011; 42: 29-41
8. Anderson BJ, Edelstein S, Abramson N.W., et al. Depressive symptoms and quality of life in adolescents with type 2 diabetes: baseline data from the TODAY study. Diabetes Care 2011; 34: 2205-2207
9. Weissberg-Benchell J., Antisdel-Lomaglio J. Diabetes-specific emotional distress among adolescents: feasibility, reliability, and validity of the problem areas in diabetes-teen version. Pediatr Diabetes 2011; 12: 341-344
10. Lustman PJ, Anderson RJ, Freedland K.E., de Groot M, Carney RM, Clouse RE Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23: 934-942
11. de Groot M., Anderson R, Freedland K.E., Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63: 619-630
12. Sullivan MD, O'Connor P, Feeney P, et al Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care 2012; 35: 1708-1715
13. Molosankwe I, Patel A, José Gagliardino J, Knapp M, McDaid D. Economic aspects of the association between diabetes and depression: a systematic review. J Affect Disord 2012; 142 (Suppl.): S42-S55
14. Egede LE. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 2004; 27: 421-428
15. Park M, Katon WJ, Wolf FM Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry 2013; 35: 217-225
16. Lin EH, Heckbert SR, Rutter C.M., et al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med 2009; 7: 414-421
17. O'Connor P.J., Narayan KM, Anderson R, et al Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial. Diabetes Care 2012; 35: 1479-1481
18. Stewart SM, Rao U, Emslie G.J., Klein D., White PC. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus. Pediatrics 2005; 115: 1315-1319
19. Kovacs M, Mukerji P, Drash A., Iyengar S. Biomedical and psychiatric risk factors for retinopathy among children with IDDM. Diabetes Care 1995; 18: 1592-1599
20. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31: 2383-2390
21. Golden SH, Lazo M, Carnethon M., et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008; 299: 2751-2759
22. Nouwen A, Nefs G, Caramlau I., et al.; European Depression in Diabetes Research Consortium. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes(EDID) Research Consortium. Diabetes Care 2011; 34: 752-762
23. Gonzalez JS, Peyrot M, McCarl L.A., et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008; 31: 2398-2403
24. Gonzalez JS, Safren SA, Cagliero E, et al Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007; 30: 2222-2227
25. Lyoo IK, Yoon S, Jacobson A.M., et al. Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression. Arch Gen Psychiatry 2012; 69: 1267-1276
26. Ho N, Sommers MS, Lucki I. Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. Neurosci Biobehav Rev 2013; 37: 1346-1362
27. Berends LM, Ozanne SE Early determinants of type-2 diabetes. Best Pract Res Clin Endocrinol Metab 2012; 26: 569-580
28. Kuzawa CW, Sweet E. Epigenetics and the embodiment of race: developmental origins of US racial disparities in cardiovascular health. Am J Hum Biol 2009; 21: 2-15
29. Kajantie E, Räikkönen K. Early life predictors of the physiological stress response later in life. Neurosci Biobehav Rev 2010; 35: 23-32
30. Phillips DI. Programming of the stress response: a fundamental mechanism underlying the long-term effects of the fetal environment? J Intern Med 2007; 261: 453-460
31. Slopen N, Koenen KC, Kubzansky LD Childhood adversity and immune and inflammatory biomarkers associated with cardiovascular risk in youth: a systematic review. Brain Behav Immun 2012; 26: 239-250
32. de Vet E., de Ridder DT, de Wit JB. Environmental correlates of physical activity and dietary behaviours among young people: a systematic review of reviews. Obes Rev 2011; 12: e130-e142
33. Papas MA, Alberg AJ, Ewing R, Helzlsouer K.J., Gary TL, Klassen AC. The built environment and obesity. Epidemiol Rev 2007; 29: 129-143
34. Auchincloss AH, Diez Roux AV, Mujahid MS, Shen M, Bertoni AG, Carnethon MR Neighborhood resources for physical activity and healthy foods and incidence of type 2 diabetes mellitus: the Multi-Ethnic study of Atherosclerosis. Arch Intern Med 2009; 169: 1698-1704
35. Mair C, Diez Roux AV, Galea S. Are neighbourhood characteristics associated with depressive symptoms? A review of evidence. J Epidemiol Community Health 2008; 62: 940-946
36. Auchincloss AH, Diez Roux AV, Brown DG, Erdmann CA, Bertoni AG. Neighborhood resources for physical activity and healthy foods and their association with insulin resistance. Epidemiology 2008; 19: 146-157
37. Skinner ML, Shirtcliff EA, Haggerty K.P., Coe CL, Catalano RF. Allostasis model facilitates understanding race differences in the diurnal cortisol rhythm. Dev Psychopathol 2011; 23: 1167-1186
38. Brenner AB, Zimmerman MA, Bauermeister J.A., Caldwell CH. The physiological expression of living in disadvantaged neighborhoods for youth. J Youth Adolesc 2013; 42: 792-806
39. Karb RA, Elliott MR, Dowd J.B., Morenoff JD. Neighborhood-level stressors, social support, and diurnal patterns of cortisol: the Chicago Community Adult Health Study. Soc Sci Med 2012; 75: 1038-1047
40. Do DP, Diez Roux AV, Hajat A, et al. Circadian rhythm of cortisol and neighborhood characteristics in a population-based sample: the Multi-Ethnic Study of Atherosclerosis. Health Place 2011; 17: 625-632
41. Dulin-Keita A., Casazza K, Fernandez J.R., Goran MI, Gower B. Do neighbourhoods matter? Neighbourhood disorder and long-term trends in serum cortisol levels. J Epidemiol Community Health 2012; 66: 24-29
42. Browning CR, Cagney KA, Iveniuk J. Neighborhood stressors and cardiovascular health: crime and C-reactive protein in Dallas, USA. Soc Sci Med 2012; 75: 1271-1279
43. Broyles ST, Staiano AE, Drazba K.T., Gupta AK, Sothern M, Katzmarzyk PT. Elevated Creactive protein in children from risky neighborhoods: evidence for a stress pathway linking neighborhoods and inflammation in children. PLoS One 2012; 7: e45419
44. Champaneri S, Wand GS, Malhotra S.S., Casagrande SS, Golden SH. Biological basis of depression in adults with diabetes. Curr Diab Rep 2010; 10: 396-405
45. Stetler C, Miller GE. Blunted cortisol response to awakening in mild to moderate depression: regulatory influences of sleep patterns and social contacts. J Abnorm Psychol 2005; 114: 697-705
46. Champaneri S, Xu X, Carnethon M.R., et al. Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. Metabolism 2012; 61: 986-995
47. Stetler C, Miller GE Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011; 73: 114-126
48. Courtet P, Olie E. Circadian dimension and severity of depression. Eur Neuropsychopharmacol 2012; 22(Suppl. 3): S476-S481
49. Gangwisch JE. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev 2009; 10(Suppl. 2): 37-45
50. Kan C, Silva N, Golden S.H., et al. Asystematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 2013; 36: 480-489
51. Holt RI, Peveler RC Antipsychotic drugs and diabetes - an application of the Austin Bradford Hill criteria. Diabetologia 2006; 49: 1467-1476
52. Barnard K, Peveler RC, Holt RI Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review. Diabetes Care 2013; 36: 3337-3345
53. Serretti A, Mandelli L Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010; 71: 1259-1272
54. van der Feltz-Cornelis CM, Nuyen J, Stoop C, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 2010; 32: 380-395
55. van der Feltz-Cornelis C. Comorbid diabetes and depression: do E-health treatments achieve better diabetes control? Diabetes Management 2013; 3: 379-388
56. Wysocki T, Harris MA, Buckloh L.M., et al. Randomized trial of behavioral family systems therapy for diabetes: maintenance of effects on diabetes outcomes in adolescents. Diabetes Care 2007; 30: 555-560
57. Katon WJ, Von Korff M, Lin EH, et al The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004; 61: 1042-1049
58. Katon W, Russo J, Lin E.H., et al. Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry 2012; 69: 506-514
59. Pouwer F, Tack CJ, Geelhoed-Duijvestijn PH, et al. Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trial. Diabetologia 2011; 54: 741-748
60. Nichols GA, Desai J, Elston Lafata J, et al.; SUPREME-DM Study Group. Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. Prev Chronic Dis 2012; 9: E110
61. Lakey SL, Gray SL, Ciechanowski P, Schwartz S., Logerfo J. Antidepressant use in nonmajor depression: secondary analysis of a Program to Encourage Active, Rewarding Lives for Seniors (PEARLS), a randomized controlled trial in older adults from 2000 to 2003. Am J Geriatr Pharmacother 2008; 6: 12-20
62. de Groot M., Doyle T, Kushnick M., et al. Can lifestyle interventions do more than reduce diabetes risk? Treating depression in adults with type 2 diabetes with exercise and cognitive behavioral therapy. Curr Diab Rep 2012; 12: 157-166
63. Disability Rights Commission. Equal Treatment: Closing the Gap. A Formal Investigation Into Physical health Inequalities Experienced by People With Learning Difficulties and Mental Health Problems. London, Disability Rights Commission, 2006
64. Mitchell AJ, Malone D, Doebbeling CC Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry 2009; 194: 491-499
65. Lawrence D, Coghlan R. Health inequalities and the health needs of people with mental illness. N S W Public Health Bull 2002; 13: 155-158
66. Frayne SM, Halanych JH, Miller D.R., et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med 2005; 165: 2631-2638
67. Crandall JP, Knowler WC, Kahn S.E., et al.; Diabetes Prevention Program Research Group. The prevention of type2 diabetes. Nat Clin Pract Endocrinol Metab 2008; 4: 382-393
68. Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012; 35: 723-730
69. Rubin RR, Ma Y, Peyrot M., et al.; Diabetes Prevention Program Research Group. Antidepressant medicine use and risk ofdeveloping diabetes during the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care 2010; 33: 2549-2551
70. Rubin RR, Ma Y, Marrero D.G., et al.; Diabetes Prevention Program Research Group. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 2008; 31: 420-426
71. Li C, Ford ES, Strine T.W., Mokdad AH. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 2008; 31: 105-107
72. Rodgers M, Asaria M, Walker S., et al. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review. Health Technol Assess 2012; 16: 1-130